89 results
8-K
EX-99.1
sge ntcvsvt
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
EX-99.1
9v0ssfkr
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
EX-99.1
bcaizi 43qmhok
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
EX-99.1
ttgdzm
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
EX-99.1
pmglg5
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
kac0zqh2osqwfp5wtugo
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
he7xhgy59er hv2uu0mq
10 Jul 23
Regulation FD Disclosure
5:13pm
8-K
EX-10.1
4b6xbyus5wtijes 8c
16 Jun 23
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.1
5y6estoiii9k0 lu
9 May 23
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:10pm